Titan Biotech Ltd

Titan Biotech Q2 FY27 Results: Net Profit ₹12.5 Cr, Up 60.3% YoY

Titan Biotech Ltd reported revenue from operations of ₹76.5 Cr (+40.6% YoY) and net profit of ₹12.5 Cr (+60.3% YoY) for Q2 FY27.

Key figure

Net profit ₹12.5 Cr · +60.3% YoY

Titan Biotech Board Meeting Date

Titan Biotech's board meets 05 November 2026 to consider unaudited quarterly and half-year results. Trading window stays closed until 48 hours after outcome declaration.

Titan Biotech Bonus Issue

Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.

Titan Biotech Other Announcement

Titan Biotech Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.